Symrise Aktie
WKN DE: SYM999 / ISIN: DE000SYM9999
08.05.2019 14:00:02
|
DGAP-News: Symrise announces Califormulations, LLC: A unique platform to foster beverage innovation
DGAP-News: Symrise AG / Key word(s): Investment
Paul Graham, President, Symrise Flavor North America, stated, "Major packaged goods companies put their focus on agile innovation to help fuel growth around their core brands. Agile venturing and creative innovation sprints will replace the traditional and often time-consuming 'stage gate' innovation funnel and are changing innovation sustainably." Califormulations, LLC fully embraces this approach. The company is run by an industry experienced management team and built on a business model that is designed for speed, agility, flexibility and focused innovation, with each investor harnessing specialized expertise. The new platform combines beverage expertise and innovation capabilities with the ability to quickly develop shelf-ready, scalable products. Customers will have access to the expertise located at three locations: the newly formed Califormulations, LLC location in Columbus, Georgia, with 100,000 sq ft for beverage development, multi-purpose production, pilot scale flexible bottling and shelf-ready, scalable packaging; Symrise's regional headquarters in Teterboro, New Jersey, providing global expertise in flavor solutions, including taste for sugar reduced products; and the specialized Symrise Beverage Center in Laguna Beach, California, to inspire creativity in beverage product concepts. Utilizing the expertise located at these three locations, Califormulations, LLC in cooperation with Symrise will deliver a rapid innovation approach composed of four integrated parts: Insights & Design, Prototyping & Evaluation, Development & Production and the Activation Ecosystem. The Symrise team brings a proven reputation in beverage innovation and incubation, a comprehensive portfolio of consumer insights, a strong footprint in beverage and CPG accounts including core listings with global brands. TGOD adds a new element to the business through their expertise in producing premium organic cannabinoids. Using sustainable growing practices, TGOD offers organic CBD and other organic cannabinoids where allowed by local laws and regulations. The end result is a unique, agile, end-to-end approach to innovation with full project management across every step. Paul Graham concluded, "The complementary capabilities of Califormulations, LLC will foster innovation and scale new, successful brands quickly." About Symrise: Symrise is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, the pharmaceutical industry and producers of nutritional supplements and pet food. Its sales of approximately EUR 3.2 billion in the 2018 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented with over 100 sites in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. Symrise - always inspiring more. www.symrise.com
Social Media: twitter.com/symriseag
08.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Symrise AG |
Mühlenfeldstraße 1 | |
37603 Holzminden | |
Germany | |
Phone: | +49 (0)5531 90 0 |
E-mail: | ir@symrise.com |
Internet: | www.symrise.com |
ISIN: | DE000SYM9999, DE000SYM7787, DE000SYM7704 |
WKN: | SYM999 |
Indices: | MDAX |
Listed: | Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 808619 |
End of News | DGAP News Service |
|
808619 08.05.2019

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Symrise AGmehr Nachrichten
12:27 |
Freundlicher Handel: LUS-DAX zeigt sich am Montagmittag fester (finanzen.at) | |
12:27 |
Freundlicher Handel in Frankfurt: DAX am Mittag im Plus (finanzen.at) | |
09.05.25 |
DAX 40-Wert Symrise-Aktie: So viel Gewinn hätte ein Investment in Symrise von vor 3 Jahren eingefahren (finanzen.at) | |
08.05.25 |
Gute Stimmung in Frankfurt: So performt der LUS-DAX nachmittags (finanzen.at) | |
08.05.25 |
Starker Wochentag in Frankfurt: DAX stärker (finanzen.at) | |
06.05.25 |
Jefferies & Company Inc. veröffentlicht Investment-Empfehlung: Symrise-Aktie mit Hold (finanzen.at) | |
06.05.25 |
Schwacher Handel in Frankfurt: LUS-DAX am Dienstagmittag in der Verlustzone (finanzen.at) | |
06.05.25 |
Verluste in Frankfurt: DAX am Dienstagmittag in der Verlustzone (finanzen.at) |
Analysen zu Symrise AGmehr Analysen
06.05.25 | Symrise Hold | Jefferies & Company Inc. | |
30.04.25 | Symrise Buy | Warburg Research | |
30.04.25 | Symrise Neutral | Goldman Sachs Group Inc. | |
30.04.25 | Symrise Buy | UBS AG | |
30.04.25 | Symrise Overweight | JP Morgan Chase & Co. |
Aktien in diesem Artikel
Symrise AG Unsponsored American Deposit Receipt Repr 1-4 Sh | 25,00 | -1,57% |
|
Symrise AG | 101,10 | -2,37% |
|